- Geyser Brands continues to strengthen its leadership team with industry leaders
- The company’s proprietary nanotechnology formulations transport therapeutic agents with superior bioavailability and efficacy
- Geyser Brands is pursuing the acquisition of Solace Management Group, solidifying its place as a leading provider of health-focused CBD and hemp products
Geyser Brands Inc. (TSX.V: GYSR), a global science-led consumer health care company, builds and markets some of the world’s leading cannabis products and brands. As a licensed producer in Canada under the Cannabis Act, Geyser operates a production and processing facility in Port Coquitlam, British Columbia, developing unique products for healthy lifestyle brands (http://cnw.fm/SdE7g).
One of Geyser’s wholly owned subsidiaries, Apothecary Botanicals, recently received a standard processing license from Health Canada. Receipt of the license was heralded by Geyser CEO Andreas Thatcher as “a huge milestone” for the company.
“The license allows us to add value to existing consumer health care brands by providing them the platform to add CBD,” Thatcher stated in a news release (http://cnw.fm/8FyOi). “It also reflects our business model to focus our licensed producer on delivering scale through manufacturing and distribution for brand companies.”
The new license allows Geyser to begin work to extend its cannabidiol products to the regulated Canadian consumer medical market as the company awaits its R&D and sales licenses. Physical modifications to the Apothecary Botanicals manufacturing facility to deliver GMP-compliant capacity are complete, with production of in-house formulated branded products expected to begin sometime in late summer.
With the completion of its proposed Solace Management Group acquisition, Geyser intends to increase its production capacity with another GMP facility dedicated to hemp-related human and pet products. These products already feature the proprietary nanotechnology for stronger, more stable offerings. The intention is to extend the Solace product and formulations into the regulated cannabis space through Geyser’s licensed producer.
Adding strength to the company’s endeavors is the recent addition of several seasoned industry leaders to its management team (http://cnw.fm/CzA14). Joining the board of directors is Dr. Bin Huang, a seasoned life sciences executive with experience in strategy and new business development, financing and public markets, corporate governance and operations management in North America and Asia.
Chartered Professional Accountant Gordon Clissold, who has over 20 years of experience as an operational and financial manager for both public and private companies, has been named chief financial officer. Clissold has also served as a past president of the Certified General Accountants of BC. These pivotal appointments to Geyser Brands’ leadership team are expected to bring valuable oversight and experience to the company as it pursues strategic goals in 2019 and beyond.
In combination with its proposed acquisition of Solace Management Group, these additions are expected to play a key role in establishing Geyser Brands as a leading provider of health-focused CBD and hemp products (http://cnw.fm/N3fHV).
For more information, visit the company’s website at www.GeyserBrands.com
NOTE TO INVESTORS: The latest news and updates relating to GYSR are available in the company’s newsroom at http://cnw.fm/GYSR
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Do you have a questions or are you interested in working with CNW? Ask Our Editor